Onkologie

Published by: S. Karger AG  

People

  1. Lowe
    Lowe
  2. Saltz
    Saltz
  3. De Angelis
    De Angelis
  4. Feldman
    Feldman
  5. Joseph
    Joseph
  6. Levine
    Levine
  7. Maki
    Maki
  8. Moore
    Moore
  9. Motzer
    Motzer
  10. Offit
    Offit

Groups

  1. Department of Medicine (7)
  2. Center for Hematologic Malignancies (5)
  3. Executive Committee, Center for Hematologic Malignancies (5)
  4. GSK Faculty (5)
  5. Sloan Kettering Institute Faculty (5)
  6. Solid Tumor Oncology Division (5)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  9. Cancer Biology and Genetics Program Faculty (3)
  10. Center for Pancreatic Cancer Research (3)
Search Within
Formats
  1. Meeting Abstract (14)
  2. Journal Article (5)
Groups
  1. Department of Medicine (7)
  2. Center for Hematologic Malignancies (5)
  3. Executive Committee, Center for Hematologic Malignancies (5)
  4. GSK Faculty (5)
  5. Sloan Kettering Institute Faculty (5)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Christoph Miething (5)
  2. Scott Lowe (3)
  3. Leonard Saltz (2)
  4. Anja Moldenhauer (1)
  5. Darren Feldman (1)
  6. David Klimstra (1)

More People

Years
  1. 2013 (4)
  2. 2012 (4)
  3. 2011 (1)
  4. 2010 (3)
  5. 2009 (1)
  6. 2008 (2)

More Years

Publishers
  1. S. Karger AG (19)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Active STAT3 is frequently expressed in esophageal squamous cell carcinoma but not Barrett adenocarcinomas
    Meeting Abstract

    Lassmann, S.; Schoepflin, A.; Hauschke, D.; Tang, L.; Klimstra, D.; Werner, M.
    Onkologie (2010)

    Fulltext@MSK | Save
  • Future studies in PCNSL: What are the goals?
    Meeting Abstract

    De Angelis, L. M.
    Onkologie (2010)

    Fulltext@MSK | Save
  • Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer
    Journal Article

    Morris, P. G.; Bach, P. B.
    Onkologie (2009)

    Fulltext@MSK | Save
  • Defining the apoptotic pathways underlying HDAC inhibitor-mediated tumor therapy in vivo
    Meeting Abstract

    Lindemann, R.; Newbold, A.; Whitecross, K.; Cluse, L.; Frew, A.; Ellis, L.; Williams, S.; Wiegmans, A.; Dear, A.; Scott, C.; more...
    Onkologie (2008)

    Fulltext@MSK | Save
  • Sunitinib versus interferon-alpha for first-line treatment of metastatic renal cell carcinoma: Updated results and further prognostic factor analyses
    Meeting Abstract

    Grünwald, V.; Eberhardt, W.; Ringhoffer, M.; Jakse, G.; Motzer, R. J.
    Onkologie (2008)

    Fulltext@MSK | Save
  • Size matters - What can we learn from a small randomized trial?
    Journal Article

    Saltz, L.
    Onkologie (2007)

    Fulltext@MSK | Save
  • For small renal tumors, kidney sparing surgery provides local tumor control and prevents chronic kidney disease
    Journal Article

    Russo, P.
    Onkologie (2007)

    Fulltext@MSK | Save
  • Oxaliplatin beim Kolorektalkarzinom: Neue Daten zu First-lineund adjuvanter Therapie
    Journal Article

    Goldberg, R. M.; Saltz, L.; Grem, J. L.; Lenz, H. J.
    Onkologie (2002)

    Fulltext@MSK | Save
  • TNF-alpha-dependent increase of adenoviral transduction in CD34(+) hematopoietic progenitor cells correlates with capping of the adenovirus at the cell surface
    Meeting Abstract

    Moldenhauer, A.; Leopold, P. L.; Shieh, J. H.; Crystal, R. C.; Moore, M. A. S.
    Onkologie (2000)

    Fulltext@MSK | Save

    • Onkologie – authorized name for:

    Name ISSN / ISBN Publisher
    Onkologie 0378584X Unknown
    Onkologie 0378-584X S. Karger AG
    Onkologie 0378584X S. Karger AG
    Onkologie 0378-584X S. Karger AG
    Onkologie 0378-584X Unknown
    Onkologie 0378-584X Karger